Status:
RECRUITING
One vs. Two Stents for Gallbladder Disease
Lead Sponsor:
Mayo Clinic
Conditions:
Recurrent Cholecystitis
Cholecystitis
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
This randomized trial will look at whether placing two cystic duct stents is more effective than one cystic duct stent in preventing recurrent gallbladder disease (cholecystitis, gallstone pancreatiti...
Eligibility Criteria
Inclusion
- Males or non-pregnant females presenting with cholecystitis, biliary colic or gallstone pancreatitis.
- Age 18-95.
- Participants must be willing and able to provide informed consent
- Referred for ERCP for management of 1) suspected choledocholithiasis 2) acute biliary pancreatitis and/or 3) acute cholangitis in whom cholecystectomy is expected to be delayed \> 30 days or are deemed to not be surgical candidates for cholecystectomy.
Exclusion
- Inability to provide informed consent
- History of surgically altered upper gastrointestinal anatomy (e.g. Roux-en-Y gastric bypass, Billroth I/II) precluding standard ERCP
- History of primary sclerosing cholangitis
- History of gallbladder cancer
- History of cholecystectomy
- Unsuccessful biliary cannulation during ERCP -
Key Trial Info
Start Date :
December 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 27 2028
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07222527
Start Date
December 12 2025
End Date
May 27 2028
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905